- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06071117
EFFECTIVENESS OF VIRTUAL REALITY GLASSES VERSUS WHITE NOISE ON DENTAL ANXIETY IN CHILDREN WITH ATTENTION DEFICIT/ HYPERACTIVITY DISORDER
EFFECTIVENESS OF VIRTUAL REALITY GLASSES VERSUS WHITE NOISE ON DENTAL ANXIETY IN CHILDREN WITH ATTENTION DEFICIT/ HYPERACTIVITY DISORDER(A RANDOMIZED CONTROLLED CLINICAL TRIAL)
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Alexandria, Egypt
- Pediatric Neurology Outpatient Clinic, Faculty of Medicine, Alexandria University, Egypt
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Children diagnosed with ADHD according to the DSM-V criteria and diagnosis confirmed by a pediatric neurologist.
- All children should be on stimulant medication.
- No previous dental experience.
- Written consent of the legal guardian.
Exclusion Criteria:
- Children with physical disabilities or other psychiatric disorders.
- Children with visual or hearing disabilities.
- Patients requiring emergency treatment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Virtual Reality Glasses (VR)
|
Children allocated to this group will be distracted using VR glasses during dental treatment which is an individual headset that has earphones incorporated.
Age-appropriate cartoons and movies will be shown to the children.
The VR glasses will be then introduced to the children.
The children will be given time to accommodate with the device before starting the procedure.
The VR glasses will be applied during the dental examination and treatment.
|
|
Active Comparator: White noise
|
Wireless kids' headphones will be introduced to the children allocated to this group. They will be given some time to accommodate with the headphones. Then, the white noise will be played and children will be asked to concentrate on the music during the procedure. White noise stimulus will be set at 70 decibels, within the "normal conversation" volume range and below what is considered harmful to hearing. The white noise of rain sound, managed with an iPhone application called Muse. The decibel level of white noise will be calibrated using a portable digital sound level meter |
|
Sham Comparator: Basic behavior management techniques
|
Children allocated to this group will be managed by the basic behavior guidance techniques: (Tell-Show-Do).
No adjunctive distraction tool will be used.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dental anxiety assessment
Time Frame: up to one week
|
This will be assessed using Facial Image Scale (FIS).
The FIS comprises one item with a response set of five faces (ranging from a very sad to a very smiley face).
Children will be asked to indicate which of the faces they feel most like at that moment, it is a 'state' measure of anxiety that provides an immediate reflection of how the child is feeling.
|
up to one week
|
|
Pulse rate
Time Frame: up to one week
|
The pulse rate will be measured using a pulse oximeter.
Normal range is considered from 70-110.
|
up to one week
|
|
Level of cooperation
Time Frame: up to one week
|
Venham's Behavior rating scale (VBRS) will be used to evaluate the overall child's behavior.
The changes will be recorded to assess the change in the child's cooperation during the procedure.
Venham's Behavior rating scale classifies the child's behavior into 6 categories with scores ranging from 0 to 5. A score of 0 means total cooperation and a score of 5 refers to complete absence of compliance and cooperation and the requirement of physical restraint.
The operator will assign a score to each child based on the child's behavior by analysis of the recorded videotape.
|
up to one week
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Nahla A Aly, BDS, Alexandria University
- Study Director: Amina M AbdElrahman, PhD, Alexandria University
- Study Chair: Karin ML Dowidar, PhD, Alexandria University
- Study Director: Tarek Omar, PhD, University of Alexandria
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0646-03/2023
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.